TONYA ANDERSON: Open Payments
NPI 1538234455 · MINOT, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 21 payments from 9 companies in 2025. Trend: 2023 $526 · 2024 $610 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| Alkermes, Inc. | 4 | $83 |
| Collegium Pharmaceutical, Inc. | 4 | $77 |
| Lundbeck LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: ARISTADA, Jornay PM, REXULTI, TRINTELLIX, VRAYLAR, FRUZAQLA, ICLUSIG, UZEDY.
Industry payments across ND — which companies pay providers there.
